Close Menu

NEW YORK (360Dx) – Kypha said today that it has secured $4 million in Series A funding that it will use to complete the integration and expand manufacturing capacity of recently acquired Biosensia and its ISO 13485-certified facilities in Dublin, Ireland.

Saint Louis, Missouri-based Kypha said that it will also use the funds to support the commercial launch of additional tests and to expand partnerships with pharmaceutical companies advancing promising therapies for immune disorders.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.